Evidence map›Paper›PMID 33459759›Full record

ArticleBiology of reproduction2021

Male fetal sex affects uteroplacental angiogenesis in growth restriction mouse model†.

Jessica F Hebert, Jess A Millar, Rahul Raghavan, Amie Romney, Jason E Podrabsky, Monique Y Rennie, Allison M Felker, Perrie O'Tierney-Ginn, Mayu Morita, Elizabeth A DuPriest and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biology of reproduction, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Placenta's Role in Sexually Dimorphic Fetal Growth Strategies.Reproductive sciences (Thousand Oaks, Calif.) · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jessica F HebertDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA.
Jess A MillarDepartment of Biology, Portland State University, Portland, OR, USA.
Rahul RaghavanDepartment of Biology, Portland State University, Portland, OR, USA.
Amie RomneyDepartment of Biology, Portland State University, Portland, OR, USA.
Jason E PodrabskyDepartment of Biology, Portland State University, Portland, OR, USA.
Monique Y RennieCenter for Developmental Health, Oregon Health & Science University, Portland, OR, USA.
Allison M FelkerDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Perrie O'Tierney-GinnMother Infant Research Institute, Tufts Medical Center, Boston, MA, USA.
Mayu MoritaDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA.
Elizabeth A DuPriestCenter for Developmental Health, Oregon Health & Science University, Portland, OR, USA.
Terry K MorganDepartment of Pathology, Oregon Health & Science University, Portland, OR, USA.
Portland State University · USOregon Health & Science University · USMcMaster University · CATufts Medical Center · US

Funding

Scholars in Women's Health Research Across the LifespanK12HD043488 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MYATT, LESLIE · 2002 to 2023
$10.4M
Role of Placental Insufficiency in Preeclampsia, IUGR, and Fetal Programming of HR21HD068896 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORGAN, TERRY KNUD · 2012 to 2013
$414k
NICHD NIH HHS K12 HD043488NICHD NIH HHS R21 HD068896
6 · The paper itself

Abstract

Abnormally increased angiotensin II activity related to maternal angiotensinogen (AGT) genetic variants, or aberrant receptor activation, is associated with small-for-gestational-age babies and abnormal uterine spiral artery remodeling in humans. Our group studies a murine AGT gene titration transgenic (TG; 3-copies of the AGT gene) model, which has a 20% increase in AGT expression mimicking a common human AGT genetic variant (A[-6]G) associated with intrauterine growth restriction (IUGR) and spiral artery pathology. We hypothesized that aberrant maternal AGT expression impacts pregnancy-induced uterine spiral artery angiogenesis in this mouse model leading to IUGR. We controlled for fetal sex and fetal genotype (e.g., only 2-copy wild-type [WT] progeny from WT and TG dams were included). Uteroplacental samples from WT and TG dams from early (days 6.5 and 8.5), mid (d12.5), and late (d16.5) gestation were studied to assess uterine natural killer (uNK) cell phenotypes, decidual metrial triangle angiogenic factors, placental growth and capillary density, placental transcriptomics, and placental nutrient transport. Spiral artery architecture was evaluated at day 16.5 by contrast-perfused three-dimensional microcomputed tomography (3D microCT). Our results suggest that uteroplacental angiogenesis is significantly reduced in TG dams at day 16.5. Males from TG dams are associated with significantly reduced uteroplacental angiogenesis from early to late gestation compared with their female littermates and WT controls. Angiogenesis was not different between fetal sexes from WT dams. We conclude that male fetal sex compounds the pathologic impact of maternal genotype in this mouse model of growth restriction.

Indexed as

Neovascularization, PathologicAnimalsDisease Models, AnimalFemaleFetal DevelopmentFetal Growth RetardationFetusKiller Cells, NaturalMaleMiceMice, Inbred C57BLPlacentaPlacentationPregnancySex CharacteristicsSex Differentiationangiogenesisintrauterine growth restrictionplacentaplacental transport

Identifiers

PMID33459759
PMCPMC8023425
OpenAlexW3125367109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.